ID   KKCC1_RAT               Reviewed;         505 AA.
AC   P97756; Q64572; Q794E3;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   23-FEB-2022, entry version 149.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase kinase 1;
DE            Short=CaM-KK 1;
DE            Short=CaM-kinase kinase 1;
DE            Short=CaMKK 1;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM-kinase IV kinase;
DE   AltName: Full=Calcium/calmodulin-dependent protein kinase kinase alpha;
DE            Short=CaM-KK alpha;
DE            Short=CaM-kinase kinase alpha;
DE            Short=CaMKK alpha;
GN   Name=Camkk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 214-230 AND 291-310,
RP   FUNCTION, ACTIVITY REGULATION, INTERACTION WITH CALMODULIN, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7642608; DOI=10.1074/jbc.270.33.19320;
RA   Tokumitsu H., Enslen H., Soderling T.R.;
RT   "Characterization of a Ca2+/calmodulin-dependent protein kinase cascade.
RT   Molecular cloning and expression of calcium/calmodulin-dependent protein
RT   kinase kinase.";
RL   J. Biol. Chem. 270:19320-19324(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8827455; DOI=10.1093/oxfordjournals.jbchem.a021365;
RA   Okuno S., Kitani T., Fujisawa H.;
RT   "Evidence for the existence of Ca2+/calmodulin-dependent protein kinase IV
RT   kinase isoforms in rat brain.";
RL   J. Biochem. 119:1176-1181(1996).
RN   [3]
RP   PROTEIN SEQUENCE OF 4-13; 20-38; 50-60; 137-148; 196-210; 275-288; 291-311;
RP   333-340; 351-360; 365-382; 389-397; 405-408; 440-444; 458-468 AND 473-478,
RP   FUNCTION IN PHOSPHORYLATION OF CAMK1 AND CAMK4, AND AUTOPHOSPHORYLATION.
RX   PubMed=8631893; DOI=10.1074/jbc.271.18.10806;
RA   Edelman A.M., Mitchelhill K.I., Selbert M.A., Anderson K.A., Hook S.S.,
RA   Stapleton D., Goldstein E.G., Means A.R., Kemp B.E.;
RT   "Multiple Ca(2+)-calmodulin-dependent protein kinase kinases from rat
RT   brain. Purification, regulation by Ca(2+)-calmodulin, and partial amino
RT   acid sequence.";
RL   J. Biol. Chem. 271:10806-10810(1996).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=8929978; DOI=10.1016/0304-3940(96)12317-x;
RA   Nakamura Y., Okuno S., Kitani T., Otake K., Sato F., Fujisawa H.;
RT   "Distribution of Ca2+/calmodulin-dependent protein kinase kinase alpha in
RT   the rat central nervous system: an immunohistochemical study.";
RL   Neurosci. Lett. 204:61-64(1996).
RN   [5]
RP   CHARACTERIZATION, AND REGION.
RX   PubMed=9335539; DOI=10.1021/bi971348i;
RA   Tokumitsu H., Wayman G.A., Muramatsu M.-A., Soderling T.R.;
RT   "Calcium/calmodulin-dependent protein kinase kinase: identification of
RT   regulatory domains.";
RL   Biochemistry 36:12823-12827(1997).
RN   [6]
RP   PHOSPHORYLATION AT THR-108 AND SER-458, MUTAGENESIS OF THR-108 AND SER-458,
RP   AND PHOSPHORYLATION BY PRCAKA.
RX   PubMed=9195898; DOI=10.1074/jbc.272.26.16073;
RA   Wayman G.A., Tokumitsu H., Soderling T.R.;
RT   "Inhibitory cross-talk by cAMP kinase on the calmodulin-dependent protein
RT   kinase cascade.";
RL   J. Biol. Chem. 272:16073-16076(1997).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF AKT1.
RX   PubMed=9859994; DOI=10.1038/25147;
RA   Yano S., Tokumitsu H., Soderling T.R.;
RT   "Calcium promotes cell survival through CaM-K kinase activation of the
RT   protein-kinase-B pathway.";
RL   Nature 396:584-587(1998).
RN   [8]
RP   PHOSPHORYLATION AT SER-74 AND THR-108, MUTAGENESIS OF SER-74 AND THR-108,
RP   PHOSPHORYLATION BY PRCAKA, AND TISSUE SPECIFICITY.
RX   PubMed=10187789; DOI=10.1074/jbc.274.15.10086;
RA   Matsushita M., Nairn A.C.;
RT   "Inhibition of the Ca2+/calmodulin-dependent protein kinase I cascade by
RT   cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 274:10086-10093(1999).
RN   [9]
RP   MUTAGENESIS OF ARG-172 AND ARG-177, DOMAIN RP, AND INTERACTION WITH CAMK4.
RX   PubMed=10336483; DOI=10.1074/jbc.274.22.15803;
RA   Tokumitsu H., Takahashi N., Eto K., Yano S., Soderling T.R.,
RA   Muramatsu M.-A.;
RT   "Substrate recognition by Ca2+/Calmodulin-dependent protein kinase kinase.
RT   Role of the arg-pro-rich insert domain.";
RL   J. Biol. Chem. 274:15803-15810(1999).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10651863; DOI=10.1046/j.1460-9568.2000.00883.x;
RA   Sakagami H., Umemiya M., Saito S., Kondo H.;
RT   "Distinct immunohistochemical localization of two isoforms of
RT   Ca2+/calmodulin-dependent protein kinase kinases in the adult rat brain.";
RL   Eur. J. Neurosci. 12:89-99(2000).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458 AND SER-475, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12]
RP   STRUCTURE BY NMR OF 438-463 IN COMPLEX WITH CA(2+)/CALMODULIN, MUTAGENESIS
RP   OF PHE-459 AND PHE-463, AND REGION.
RX   PubMed=10467092; DOI=10.1038/12271;
RA   Osawa M., Tokumitsu H., Swindells M.B., Kurihara H., Orita M.,
RA   Shibanuma T., Furuya T., Ikura M.;
RT   "A novel target recognition revealed by calmodulin in complex with Ca2+-
RT   calmodulin-dependent kinase kinase.";
RL   Nat. Struct. Biol. 6:819-824(1999).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that belongs to a
CC       proposed calcium-triggered signaling cascade involved in a number of
CC       cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4.
CC       Involved in regulating cell apoptosis. Promotes cell survival by
CC       phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-
CC       antagonist of cell death. {ECO:0000269|PubMed:7642608,
CC       ECO:0000269|PubMed:8631893, ECO:0000269|PubMed:9859994}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17;
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin may relieve intrasteric autoinhibition. Partially inhibited
CC       upon phosphorylation by PRCAKA/PKA. May be regulated through
CC       phosphorylation by CAMK1 and CAMK4. {ECO:0000269|PubMed:7642608}.
CC   -!- SUBUNIT: Interacts with CAMK4 and calmodulin.
CC       {ECO:0000269|PubMed:10336483, ECO:0000269|PubMed:10467092,
CC       ECO:0000269|PubMed:7642608}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- TISSUE SPECIFICITY: Mostly expressed in the brain with higher levels in
CC       cortex and hippocampus. Lower expression levels were detected in
CC       striatum, nucleus accumbens and cerebellum (at protein level). Abundant
CC       in forebrain, weaker in cerebellum and also detected in thymus and
CC       spleen. {ECO:0000269|PubMed:10187789, ECO:0000269|PubMed:7642608}.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin binding
CC       region and may be involved in intrasteric autoinhibition.
CC       {ECO:0000269|PubMed:10336483}.
CC   -!- DOMAIN: The RP domain (arginine/proline-rich) is involved in the
CC       recognition of CAMKI and CAMK4 as substrates.
CC       {ECO:0000269|PubMed:10336483}.
CC   -!- PTM: Appears to be autophosphorylated. Phosphorylated at multiple sites
CC       by PRCAKA/PKA. Phosphorylation of Ser-458 is blocked upon binding to
CC       Ca(2+)/calmodulin. May be phosphorylated by CAMK1 and CAMK4.
CC       {ECO:0000269|PubMed:10187789, ECO:0000269|PubMed:9195898}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L42810; AAC42070.1; -; mRNA.
DR   EMBL; AB023658; BAA75246.1; -; mRNA.
DR   EMBL; S83194; AAB46910.1; -; mRNA.
DR   PIR; A57156; A57156.
DR   RefSeq; NP_113850.1; NM_031662.1.
DR   PDB; 1CKK; NMR; -; B=438-463.
DR   PDBsum; 1CKK; -.
DR   BMRB; P97756; -.
DR   SMR; P97756; -.
DR   BioGRID; 248789; 3.
DR   IntAct; P97756; 4.
DR   MINT; P97756; -.
DR   STRING; 10116.ENSRNOP00000025009; -.
DR   iPTMnet; P97756; -.
DR   PhosphoSitePlus; P97756; -.
DR   PaxDb; P97756; -.
DR   GeneID; 60341; -.
DR   KEGG; rno:60341; -.
DR   CTD; 84254; -.
DR   RGD; 62023; Camkk1.
DR   eggNOG; KOG0585; Eukaryota.
DR   InParanoid; P97756; -.
DR   OrthoDB; 1044255at2759; -.
DR   PhylomeDB; P97756; -.
DR   BRENDA; 2.7.11.17; 5301.
DR   Reactome; R-RNO-111932; CaMK IV-mediated phosphorylation of CREB.
DR   Reactome; R-RNO-442729; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde.
DR   Reactome; R-RNO-9619229; Activation of RAC1 downstream of NMDARs.
DR   EvolutionaryTrace; P97756; -.
DR   PRO; PR:P97756; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IDA:RGD.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:RHEA.
DR   GO; GO:0032147; P:activation of protein kinase activity; IDA:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IDA:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:RGD.
DR   IDEAL; IID50177; -.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calmodulin-binding; Cytoplasm;
KW   Direct protein sequencing; Kinase; Methylation; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..505
FT                   /note="Calcium/calmodulin-dependent protein kinase kinase
FT                   1"
FT                   /id="PRO_0000086143"
FT   DOMAIN          128..409
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         134..142
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          27..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          167..189
FT                   /note="RP domain"
FT                   /evidence="ECO:0000269|PubMed:10336483"
FT   REGION          435..440
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000269|PubMed:10336483,
FT                   ECO:0000269|PubMed:9335539"
FT   REGION          438..463
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:10467092,
FT                   ECO:0000269|PubMed:9335539"
FT   REGION          460..505
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        275
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         157
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N5S9"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10187789"
FT   MOD_RES         78
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VBY2"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VBY2"
FT   MOD_RES         108
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:10187789,
FT                   ECO:0000269|PubMed:9195898"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:9195898,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N5S9"
FT   MUTAGEN         74
FT                   /note="S->A: Decrease in phosphorylation by PKA."
FT                   /evidence="ECO:0000269|PubMed:10187789"
FT   MUTAGEN         108
FT                   /note="T->A: Decrease in phosphorylation and partial
FT                   inhibition by PKA. Almost loss of inhibition by PKA; when
FT                   associated with A-458."
FT                   /evidence="ECO:0000269|PubMed:10187789,
FT                   ECO:0000269|PubMed:9195898"
FT   MUTAGEN         172
FT                   /note="R->E: Loss of substrate recognition and interaction
FT                   with CAMK4."
FT                   /evidence="ECO:0000269|PubMed:10336483"
FT   MUTAGEN         177
FT                   /note="R->E: Loss of substrate recognition and interaction
FT                   with CAMK4."
FT                   /evidence="ECO:0000269|PubMed:10336483"
FT   MUTAGEN         458
FT                   /note="S->A: Decrease in phosphorylation and partial
FT                   inhibition by PKA. Almost loss of inhibition by PKA; when
FT                   associated with A-108."
FT                   /evidence="ECO:0000269|PubMed:9195898"
FT   MUTAGEN         459
FT                   /note="F->D: Loss of binding to Ca(2+)/calmodulin."
FT                   /evidence="ECO:0000269|PubMed:10467092"
FT   MUTAGEN         463
FT                   /note="F->D: Loss of binding to Ca(2+)/calmodulin."
FT                   /evidence="ECO:0000269|PubMed:10467092"
FT   CONFLICT        45
FT                   /note="P -> S (in Ref. 1; AAC42070)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        81
FT                   /note="G -> E (in Ref. 1; AAC42070)"
FT                   /evidence="ECO:0000305"
FT   HELIX           444..453
FT                   /evidence="ECO:0007829|PDB:1CKK"
FT   STRAND          455..457
FT                   /evidence="ECO:0007829|PDB:1CKK"
SQ   SEQUENCE   505 AA;  55908 MW;  6B268780AC9B67E1 CRC64;
     MERSPAVCCQ DPRAELVERV AAISVAHLEE AEEGPEPASN GVDPPPRARA ASVIPGSASR
     PTPVRPSLSA RKFSLQERPA GSCLEAQVGP YSTGPASHMS PRAWRRPTIE SHHVAISDTE
     DCVQLNQYKL QSEIGKGAYG VVRLAYNERE DRHYAMKVLS KKKLLKQYGF PRRPPPRGSQ
     APQGGPAKQL LPLERVYQEI AILKKLDHVN VVKLIEVLDD PAEDNLYLVF DLLRKGPVME
     VPCDKPFPEE QARLYLRDII LGLEYLHCQK IVHRDIKPSN LLLGDDGHVK IADFGVSNQF
     EGNDAQLSST AGTPAFMAPE AISDTGQSFS GKALDVWATG VTLYCFVYGK CPFIDEYILA
     LHRKIKNEAV VFPEEPEVSE ELKDLILKML DKNPETRIGV SDIKLHPWVT KHGEEPLPSE
     EEHCSVVEVT EEEVKNSVKL IPSWTTVILV KSMLRKRSFG NPFEPQARRE ERSMSAPGNL
     LLKEGCGEGG KSPELPGVQE DEAAS
//
ID   M4K2_HUMAN              Reviewed;         820 AA.
AC   Q12851; Q86VU3;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   23-FEB-2022, entry version 198.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase kinase 2;
DE            EC=2.7.11.1;
DE   AltName: Full=B lymphocyte serine/threonine-protein kinase;
DE   AltName: Full=Germinal center kinase;
DE            Short=GC kinase;
DE   AltName: Full=MAPK/ERK kinase kinase kinase 2;
DE            Short=MEK kinase kinase 2;
DE            Short=MEKKK 2;
DE   AltName: Full=Rab8-interacting protein;
GN   Name=MAP4K2; Synonyms=GCK, RAB8IP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAA20968.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-820 (ISOFORM 1), FUNCTION, DOMAIN, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Tonsil;
RX   PubMed=7515885;
RA   Katz P., Whalen G., Kehrl J.H.;
RT   "Differential expression of a novel protein kinase in human B lymphocytes.
RT   Preferential localization in the germinal center.";
RL   J. Biol. Chem. 269:16802-16809(1994).
RN   [5]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=7477268; DOI=10.1038/377750a0;
RA   Pombo C.M., Kehrl J.H., Sanchez I., Katz P., Avruch J., Zon L.I.,
RA   Woodgett J.R., Force T., Kyriakis J.M.;
RT   "Activation of the SAPK pathway by the human STE20 homologue germinal
RT   centre kinase.";
RL   Nature 377:750-754(1995).
RN   [6]
RP   FUNCTION, AUTOPHOSPHORYLATION, AND INTERACTION WITH MAP3K1/MEKK1 AND TRAF2.
RX   PubMed=9712898; DOI=10.1074/jbc.273.35.22681;
RA   Yuasa T., Ohno S., Kehrl J.H., Kyriakis J.M.;
RT   "Tumor necrosis factor signaling to stress-activated protein kinase
RT   (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase
RT   couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and
RT   SAPK while receptor interacting protein associates with a mitogen-activated
RT   protein kinase kinase kinase upstream of MKK6 and p38.";
RL   J. Biol. Chem. 273:22681-22692(1998).
RN   [7] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH TRAF2 AND MAP3K1.
RX   PubMed=11784851; DOI=10.1128/mcb.22.3.737-749.2002;
RA   Chadee D.N., Yuasa T., Kyriakis J.M.;
RT   "Direct activation of mitogen-activated protein kinase kinase kinase MEKK1
RT   by the Ste20p homologue GCK and the adapter protein TRAF2.";
RL   Mol. Cell. Biol. 22:737-749(2002).
RN   [8]
RP   ACTIVITY REGULATION, FUNCTION, UBIQUITINATION, AND INTERACTION WITH TRAF6.
RX   PubMed=15456887; DOI=10.1128/mcb.24.20.9165-9175.2004;
RA   Zhong J., Kyriakis J.M.;
RT   "Germinal center kinase is required for optimal Jun N-terminal kinase
RT   activation by Toll-like receptor agonists and is regulated by the ubiquitin
RT   proteasome system and agonist-induced, TRAF6-dependent stabilization.";
RL   Mol. Cell. Biol. 24:9165-9175(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH MAP3K11/MLK3.
RX   PubMed=17584736; DOI=10.1074/jbc.m703422200;
RA   Zhong J., Kyriakis J.M.;
RT   "Dissection of a signaling pathway by which pathogen-associated molecular
RT   patterns recruit the JNK and p38 MAPKs and trigger cytokine release.";
RL   J. Biol. Chem. 282:24246-24254(2007).
RN   [10]
RP   REVIEW ON FUNCTION.
RX   PubMed=10026130; DOI=10.1074/jbc.274.9.5259;
RA   Kyriakis J.M.;
RT   "Signaling by the germinal center kinase family of protein kinases.";
RL   J. Biol. Chem. 274:5259-5262(1999).
RN   [11]
RP   REVIEW ON FUNCTION.
RX   PubMed=11316611; DOI=10.1016/s0962-8924(01)01980-8;
RA   Dan I., Watanabe N.M., Kusumi A.;
RT   "The Ste20 group kinases as regulators of MAP kinase cascades.";
RL   Trends Cell Biol. 11:220-230(2001).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328 AND SER-394, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Serine/threonine-protein kinase which acts as an essential
CC       component of the MAP kinase signal transduction pathway. Acts as a MAPK
CC       kinase kinase kinase (MAP4K) and is an upstream activator of the
CC       stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK)
CC       signaling pathway and to a lesser extent of the p38 MAPKs signaling
CC       pathway. Required for the efficient activation of JNKs by TRAF6-
CC       dependent stimuli, including pathogen-associated molecular patterns
CC       (PAMPs) such as polyinosine-polycytidine (poly(IC)),
CC       lipopolysaccharides (LPS), lipid A, peptidoglycan (PGN), or bacterial
CC       flagellin. To a lesser degree, IL-1 and engagement of CD40 also
CC       stimulate MAP4K2-mediated JNKs activation. The requirement for
CC       MAP4K2/GCK is most pronounced for LPS signaling, and extends to LPS
CC       stimulation of c-Jun phosphorylation and induction of IL-8. Enhances
CC       MAP3K1 oligomerization, which may relieve N-terminal mediated MAP3K1
CC       autoinhibition and lead to activation following autophosphorylation.
CC       Mediates also the SAP/JNK signaling pathway and the p38 MAPKs signaling
CC       pathway through activation of the MAP3Ks MAP3K10/MLK2 and MAP3K11/MLK3.
CC       May play a role in the regulation of vesicle targeting or fusion.
CC       regulation of vesicle targeting or fusion.
CC       {ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:15456887,
CC       ECO:0000269|PubMed:17584736, ECO:0000269|PubMed:7477268,
CC       ECO:0000269|PubMed:7515885, ECO:0000269|PubMed:9712898}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:7515885};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:7515885};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:7515885};
CC   -!- ACTIVITY REGULATION: The tumor necrosis factor (TNF), as well as
CC       endotoxins and proinflammatory stimuli such as polyinosine-polycytidine
CC       (poly(IC)), lipopolysaccharides (LPS), peptidoglycan (PGN), flagellin,
CC       or lipid A activate MAP4K2 by promoting its autophosphorylation.
CC       {ECO:0000269|PubMed:15456887, ECO:0000269|PubMed:7477268}.
CC   -!- SUBUNIT: Interacts with TRAF2, TRAF6, MAP3K1/MEKK1 and MAP3K11/MLK3.
CC       Interacts with RAB8A (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q12851; Q13233: MAP3K1; NbExp=2; IntAct=EBI-49783, EBI-49776;
CC       Q12851; Q9NUX5: POT1; NbExp=2; IntAct=EBI-49783, EBI-752420;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Basolateral cell
CC       membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.
CC       Golgi apparatus membrane {ECO:0000250}; Peripheral membrane protein
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q12851-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12851-2; Sequence=VSP_054134;
CC   -!- TISSUE SPECIFICITY: Highly expressed in germinal center but not mantle
CC       zone B-cells. Also expressed in lung, brain and placenta and at lower
CC       levels in other tissues examined. {ECO:0000269|PubMed:7515885}.
CC   -!- DOMAIN: The PEST domains are Pro-, Glu-, Ser-, and Thr-rich domains.
CC       Proteins with PEST domains are frequently targets of degradation by the
CC       ubiquitin proteasome. {ECO:0000269|PubMed:7515885}.
CC   -!- PTM: Polyubiquitinated through 'Lys-48'-polyubiquitin chains, allowing
CC       proteasomal turnover. Ubiquitination requires the kinase activity of
CC       MAP4K2/GCK. {ECO:0000269|PubMed:15456887}.
CC   -!- PTM: Autophosphorylated in response to tumor necrosis factor (TNF),
CC       endotoxins or proinflammatory stimuli. Autophosphorylation leads to
CC       activation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA20968.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP001462; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74302.1; -; Genomic_DNA.
DR   EMBL; BC047865; AAH47865.1; -; mRNA.
DR   EMBL; U07349; AAA20968.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS8082.1; -. [Q12851-1]
DR   CCDS; CCDS81582.1; -. [Q12851-2]
DR   PIR; A53714; A53714.
DR   RefSeq; NP_001294919.1; NM_001307990.1. [Q12851-2]
DR   RefSeq; NP_004570.2; NM_004579.4. [Q12851-1]
DR   SMR; Q12851; -.
DR   BioGRID; 111809; 93.
DR   IntAct; Q12851; 14.
DR   MINT; Q12851; -.
DR   STRING; 9606.ENSP00000294066; -.
DR   BindingDB; Q12851; -.
DR   ChEMBL; CHEMBL5330; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q12851; -.
DR   GuidetoPHARMACOLOGY; 2086; -.
DR   iPTMnet; Q12851; -.
DR   PhosphoSitePlus; Q12851; -.
DR   BioMuta; MAP4K2; -.
DR   DMDM; 215274019; -.
DR   CPTAC; CPTAC-862; -.
DR   CPTAC; CPTAC-863; -.
DR   EPD; Q12851; -.
DR   jPOST; Q12851; -.
DR   MassIVE; Q12851; -.
DR   MaxQB; Q12851; -.
DR   PaxDb; Q12851; -.
DR   PeptideAtlas; Q12851; -.
DR   PRIDE; Q12851; -.
DR   ProteomicsDB; 58984; -. [Q12851-1]
DR   ProteomicsDB; 70069; -.
DR   Antibodypedia; 2060; 251 antibodies from 28 providers.
DR   DNASU; 5871; -.
DR   Ensembl; ENST00000294066; ENSP00000294066; ENSG00000168067.
DR   Ensembl; ENST00000377350; ENSP00000366567; ENSG00000168067. [Q12851-2]
DR   GeneID; 5871; -.
DR   KEGG; hsa:5871; -.
DR   MANE-Select; ENST00000294066.7; ENSP00000294066.2; NM_004579.5; NP_004570.2.
DR   UCSC; uc001obh.4; human. [Q12851-1]
DR   CTD; 5871; -.
DR   DisGeNET; 5871; -.
DR   GeneCards; MAP4K2; -.
DR   HGNC; HGNC:6864; MAP4K2.
DR   HPA; ENSG00000168067; Low tissue specificity.
DR   MIM; 603166; gene.
DR   neXtProt; NX_Q12851; -.
DR   OpenTargets; ENSG00000168067; -.
DR   PharmGKB; PA30610; -.
DR   VEuPathDB; HostDB:ENSG00000168067; -.
DR   eggNOG; KOG0576; Eukaryota.
DR   GeneTree; ENSGT00940000162250; -.
DR   InParanoid; Q12851; -.
DR   OMA; AAITWIH; -.
DR   OrthoDB; 996262at2759; -.
DR   PhylomeDB; Q12851; -.
DR   TreeFam; TF105121; -.
DR   PathwayCommons; Q12851; -.
DR   SignaLink; Q12851; -.
DR   SIGNOR; Q12851; -.
DR   BioGRID-ORCS; 5871; 29 hits in 1051 CRISPR screens.
DR   GeneWiki; MAP4K2; -.
DR   GenomeRNAi; 5871; -.
DR   Pharos; Q12851; Tchem.
DR   PRO; PR:Q12851; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q12851; protein.
DR   Bgee; ENSG00000168067; Expressed in blood and 176 other tissues.
DR   ExpressionAtlas; Q12851; baseline and differential.
DR   Genevisible; Q12851; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0008349; F:MAP kinase kinase kinase kinase activity; IBA:GO_Central.
DR   GO; GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:RHEA.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0007254; P:JNK cascade; TAS:ProtInc.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006903; P:vesicle targeting; IEA:Ensembl.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR021160; MAPKKKK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038172; MAPKKKK; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Cytoplasm;
KW   Golgi apparatus; Immunity; Innate immunity; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Stress response; Transferase;
KW   Ubl conjugation.
FT   CHAIN           1..820
FT                   /note="Mitogen-activated protein kinase kinase kinase
FT                   kinase 2"
FT                   /id="PRO_0000086275"
FT   DOMAIN          16..273
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          482..793
FT                   /note="CNH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00795"
FT   NP_BIND         22..30
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          294..314
FT                   /note="PEST1"
FT   REGION          344..360
FT                   /note="PEST2"
FT   REGION          387..442
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          405..448
FT                   /note="PEST3"
FT   COMPBIAS        409..438
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        136
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         45
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         328
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         426..433
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054134"
FT   CONFLICT        120
FT                   /note="A -> R (in Ref. 4; AAA20968)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   820 AA;  91556 MW;  A59C1E99BFFAEF41 CRC64;
     MALLRDVSLQ DPRDRFELLQ RVGAGTYGDV YKARDTVTSE LAAVKIVKLD PGDDISSLQQ
     EITILRECRH PNVVAYIGSY LRNDRLWICM EFCGGGSLQE IYHATGPLEE RQIAYVCREA
     LKGLHHLHSQ GKIHRDIKGA NLLLTLQGDV KLADFGVSGE LTASVAKRRS FIGTPYWMAP
     EVAAVERKGG YNELCDVWAL GITAIELGEL QPPLFHLHPM RALMLMSKSS FQPPKLRDKT
     RWTQNFHHFL KLALTKNPKK RPTAEKLLQH PFTTQQLPRA LLTQLLDKAS DPHLGTPSPE
     DCELETYDMF PDTIHSRGQH GPAERTPSEI QFHQVKFGAP RRKETDPLNE PWEEEWTLLG
     KEELSGSLLQ SVQEALEERS LTIRSASEFQ ELDSPDDTMG TIKRAPFLGP LPTDPPAEEP
     LSSPPGTLPP PPSGPNSSPL LPTAWATMKQ REDPERSSCH GLPPTPKVHM GACFSKVFNG
     CPLRIHAAVT WIHPVTRDQF LVVGAEEGIY TLNLHELHED TLEKLISHRC SWLYCVNNVL
     LSLSGKSTHI WAHDLPGLFE QRRLQQQVPL SIPTNRLTQR IIPRRFALST KIPDTKGCLQ
     CRVVRNPYTG ATFLLAALPT SLLLLQWYEP LQKFLLLKNF SSPLPSPAGM LEPLVLDGKE
     LPQVCVGAEG PEGPGCRVLF HVLPLEAGLT PDILIPPEGI PGSAQQVIQV DRDTILVSFE
     RCVRIVNMQG EPTATLAPEL TFDFPIETVV CLQDSVLAFW SHGMQGRSLD TNEVTQEITD
     ETRIFRVLGA HRDIILESIP TDNPEAHSNL YILTGHQSTY
//
ID   MP2K4_MOUSE             Reviewed;         397 AA.
AC   P47809;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   23-FEB-2022, entry version 176.
DE   RecName: Full=Dual specificity mitogen-activated protein kinase kinase 4;
DE            Short=MAP kinase kinase 4;
DE            Short=MAPKK 4;
DE            EC=2.7.12.2;
DE   AltName: Full=C-JUN N-terminal kinase kinase 1;
DE            Short=JNK kinase 1;
DE            Short=JNKK 1;
DE   AltName: Full=JNK-activating kinase 1;
DE   AltName: Full=MAPK/ERK kinase 4;
DE            Short=MEK 4;
DE   AltName: Full=SAPK/ERK kinase 1;
DE            Short=SEK1;
GN   Name=Map2k4; Synonyms=Jnkk1, Mek4, Mkk4, Prkmk4, Sek1, Serk1, Skk1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND MUTAGENESIS OF LYS-129.
RC   TISSUE=Embryo;
RX   PubMed=7997269; DOI=10.1038/372794a0;
RA   Sanchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J.,
RA   Kyriakis J.M., Zon L.I.;
RT   "Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating
RT   transcription factor c-Jun.";
RL   Nature 372:794-798(1994).
RN   [2]
RP   SEQUENCE REVISION.
RA   Zon L.I.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION.
RX   PubMed=9620683; DOI=10.1016/s1074-7613(00)80567-1;
RA   Swat W., Fujikawa K., Ganiatsas S., Yang D., Xavier R.J., Harris N.L.,
RA   Davidson L., Ferrini R., Davis R.J., Labow M.A., Flavell R.A., Zon L.I.,
RA   Alt F.W.;
RT   "SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid
RT   compartment but not for lymphocyte development.";
RL   Immunity 8:625-634(1998).
RN   [4]
RP   ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND FUNCTION OF THE MKK/JNK
RP   PATHWAY.
RX   PubMed=9891090; DOI=10.1128/mcb.19.2.1569;
RA   Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., Davis R.J.;
RT   "The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases.";
RL   Mol. Cell. Biol. 19:1569-1581(1999).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=10095085; DOI=10.1016/s0169-328x(99)00035-2;
RA   Lee J.K., Hwang W.S., Lee Y.D., Han P.L.;
RT   "Dynamic expression of SEK1 suggests multiple roles of the gene during
RT   embryogenesis and in adult brain of mice.";
RL   Brain Res. Mol. Brain Res. 66:133-140(1999).
RN   [6]
RP   FUNCTION.
RX   PubMed=11390361; DOI=10.1101/gad.888501;
RA   Tournier C., Dong C., Turner T.K., Jones S.N., Flavell R.A., Davis R.J.;
RT   "MKK7 is an essential component of the JNK signal transduction pathway
RT   activated by proinflammatory cytokines.";
RL   Genes Dev. 15:1419-1426(2001).
RN   [7]
RP   PHOSPHORYLATION, AND INTERACTION WITH MAP3K1/MEKK1.
RX   PubMed=12401521; DOI=10.1016/s0898-6568(02)00056-6;
RA   Tu Z., Mooney S.M., Lee F.S.;
RT   "A subdomain of MEKK1 that is critical for binding to MKK4.";
RL   Cell. Signal. 15:65-77(2003).
RN   [8]
RP   FUNCTION.
RX   PubMed=12624093; DOI=10.1074/jbc.m213182200;
RA   Kishimoto H., Nakagawa K., Watanabe T., Kitagawa D., Momose H., Seo J.,
RA   Nishitai G., Shimizu N., Ohata S., Tanemura S., Asaka S., Goto T.,
RA   Fukushi H., Yoshida H., Suzuki A., Sasaki T., Wada T., Penninger J.M.,
RA   Nishina H., Katada T.;
RT   "Different properties of SEK1 and MKK7 in dual phosphorylation of stress-
RT   induced activated protein kinase SAPK/JNK in embryonic stem cells.";
RL   J. Biol. Chem. 278:16595-16601(2003).
RN   [9]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=17875933; DOI=10.1128/mcb.00226-07;
RA   Wang X., Nadarajah B., Robinson A.C., McColl B.W., Jin J.W.,
RA   Dajas-Bailador F., Boot-Handford R.P., Tournier C.;
RT   "Targeted deletion of the mitogen-activated protein kinase kinase 4 gene in
RT   the nervous system causes severe brain developmental defects and premature
RT   death.";
RL   Mol. Cell. Biol. 27:7935-7946(2007).
RN   [10]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=19265040; DOI=10.1161/circresaha.108.188292;
RA   Liu W., Zi M., Jin J., Prehar S., Oceandy D., Kimura T.E., Lei M.,
RA   Neyses L., Weston A.H., Cartwright E.J., Wang X.;
RT   "Cardiac-specific deletion of mkk4 reveals its role in pathological
RT   hypertrophic remodeling but not in physiological cardiac growth.";
RL   Circ. Res. 104:905-914(2009).
RN   [11]
RP   REVIEW ON ACTIVITY REGULATION.
RX   PubMed=17496909; DOI=10.1038/sj.onc.1210392;
RA   Raman M., Chen W., Cobb M.H.;
RT   "Differential regulation and properties of MAPKs.";
RL   Oncogene 26:3100-3112(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88; SER-255 AND THR-259, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [13]
RP   REVIEW ON FUNCTION.
RX   PubMed=20801953; DOI=10.1093/jb/mvq098;
RA   Asaoka Y., Nishina H.;
RT   "Diverse physiological functions of MKK4 and MKK7 during early
RT   embryogenesis.";
RL   J. Biochem. 148:393-401(2010).
RN   [14]
RP   REVIEW ON REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=21333379; DOI=10.1016/j.ejcb.2010.11.008;
RA   Haeusgen W., Herdegen T., Waetzig V.;
RT   "The bottleneck of JNK signaling: molecular and functional characteristics
RT   of MKK4 and MKK7.";
RL   Eur. J. Cell Biol. 90:536-544(2011).
RN   [15]
RP   INTERACTION WITH SPAG9.
RX   PubMed=12391307; DOI=10.1073/pnas.232310199;
RA   Lee C.M., Onesime D., Reddy C.D., Dhanasekaran N., Reddy E.P.;
RT   "JLP: a scaffolding protein that tethers JNK/p38MAPK signaling modules and
RT   transcription factors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14189-14194(2002).
RN   [16]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-56, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Dual specificity protein kinase which acts as an essential
CC       component of the MAP kinase signal transduction pathway. Essential
CC       component of the stress-activated protein kinase/c-Jun N-terminal
CC       kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the
CC       only known kinase to directly activate the stress-activated protein
CC       kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3.
CC       MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation,
CC       but they differ in their preference for the phosphorylation site in the
CC       Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the
CC       Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of
CC       the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK
CC       activation at least in response to proinflammatory cytokines, while
CC       other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which
CC       synergistically phosphorylate JNKs. MAP2K4 is required for maintaining
CC       peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also
CC       involved in mitochondrial death signaling pathway, including the
CC       release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7
CC       exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38
CC       MAPKs MAPK11, MAPK12, MAPK13 and MAPK14. {ECO:0000269|PubMed:11390361,
CC       ECO:0000269|PubMed:12624093, ECO:0000269|PubMed:7997269,
CC       ECO:0000269|PubMed:9620683, ECO:0000269|PubMed:9891090}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.2;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.2;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.2;
CC   -!- ACTIVITY REGULATION: Activated in response to a variety of cellular
CC       stresses, including UV and gamma-irradiation, heat shock,
CC       hyperosmolarity, T-cell receptor stimulation, peroxide and inflammatory
CC       cytokines. Also activated by developmental cues. MAP2K4/MKK4 is
CC       activated by the majority of MKKKs, such as MAP3K5/ASK1, MAP3K1/MEKK1,
CC       MAP3K7/TAK1, MAP3K10/MLK2, MAP3K11/MLK3, MAP3K12/DLK and MAP3K13/LZK.
CC       {ECO:0000269|PubMed:9891090}.
CC   -!- SUBUNIT: Interacts with SPAG9. Interacts (via its D domain) with its
CC       substrates MAPK8/JNK1, MAPK9/JNK2, MAPK10/JNK3, MAPK11 and MAPK14 (By
CC       similarity). Interacts (via its DVD domain) with MAP3Ks activators like
CC       MAP3K1/MEKK1 and MAP3K11/MLK3. Interacts with ARRB1, ARRB2 and
CC       MAPK8IP3/JIP3 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P47809; P53349: Map3k1; NbExp=2; IntAct=EBI-447934, EBI-447913;
CC       P47809; Q9ESN9-2: Mapk8ip3; NbExp=3; IntAct=EBI-447934, EBI-9549291;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9891090}. Nucleus
CC       {ECO:0000269|PubMed:9891090}.
CC   -!- TISSUE SPECIFICITY: Strong expression is detected in most of the
CC       central nervous system and in liver and thymus during early stages of
CC       development. While expression in nervous system increases over time,
CC       expression in fetal liver and thymus gradually decreases as
CC       embryogenesis proceeds. High level of expression in the central nervous
CC       system persists throughout postnatal development and remained at a
CC       stable level in adult brain. {ECO:0000269|PubMed:10095085}.
CC   -!- DOMAIN: The DVD domain (residues 362-385) contains a conserved docking
CC       site and is found in the mammalian MAP kinase kinases (MAP2Ks). The DVD
CC       sites bind to their specific upstream MAP kinase kinase kinases
CC       (MAP3Ks) and are essential for activation (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The D domain (residues 35-50) contains a conserved docking site
CC       and is required for the binding to MAPk substrates.
CC   -!- PTM: Activated by phosphorylation on Ser-255 and Thr-259 by MAP kinase
CC       kinase kinases (MAP3Ks). {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Causes irregular alignment of Purkinje cells in
CC       the cerebellum and delayed radial migration in the cortex during brain
CC       development. The cardiac-specific deletion prevents pathological
CC       cardiac hypertrophy. {ECO:0000269|PubMed:17875933,
CC       ECO:0000269|PubMed:19265040}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U18310; AAB81554.1; -; mRNA.
DR   CCDS; CCDS24844.1; -.
DR   PIR; S52423; S52423.
DR   RefSeq; NP_033183.1; NM_009157.5.
DR   SMR; P47809; -.
DR   BioGRID; 204952; 17.
DR   CORUM; P47809; -.
DR   DIP; DIP-869N; -.
DR   IntAct; P47809; 4.
DR   STRING; 10090.ENSMUSP00000041282; -.
DR   ChEMBL; CHEMBL2201; -.
DR   iPTMnet; P47809; -.
DR   PhosphoSitePlus; P47809; -.
DR   EPD; P47809; -.
DR   jPOST; P47809; -.
DR   PaxDb; P47809; -.
DR   PeptideAtlas; P47809; -.
DR   PRIDE; P47809; -.
DR   ProteomicsDB; 295582; -.
DR   Antibodypedia; 3571; 1402 antibodies from 42 providers.
DR   DNASU; 26398; -.
DR   Ensembl; ENSMUST00000046963; ENSMUSP00000041282; ENSMUSG00000033352.
DR   GeneID; 26398; -.
DR   KEGG; mmu:26398; -.
DR   UCSC; uc007jlb.1; mouse.
DR   CTD; 6416; -.
DR   MGI; MGI:1346869; Map2k4.
DR   VEuPathDB; HostDB:ENSMUSG00000033352; -.
DR   eggNOG; KOG1006; Eukaryota.
DR   GeneTree; ENSGT00940000154744; -.
DR   HOGENOM; CLU_000288_63_23_1; -.
DR   InParanoid; P47809; -.
DR   OMA; KQRHIPE; -.
DR   PhylomeDB; P47809; -.
DR   TreeFam; TF350701; -.
DR   BRENDA; 2.7.12.2; 3474.
DR   Reactome; R-MMU-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-MMU-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-MMU-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   BioGRID-ORCS; 26398; 5 hits in 64 CRISPR screens.
DR   ChiTaRS; Map2k4; mouse.
DR   PRO; PR:P47809; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; P47809; protein.
DR   Bgee; ENSMUSG00000033352; Expressed in frontal cortex and 332 other tissues.
DR   ExpressionAtlas; P47809; baseline and differential.
DR   Genevisible; P47809; MM.
DR   GO; GO:0030424; C:axon; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0032839; C:dendrite cytoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0043204; C:perikaryon; ISO:MGI.
DR   GO; GO:0005524; F:ATP binding; ISO:MGI.
DR   GO; GO:0008545; F:JUN kinase kinase activity; ISO:MGI.
DR   GO; GO:0004708; F:MAP kinase kinase activity; ISO:MGI.
DR   GO; GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; ISO:MGI.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0061049; P:cell growth involved in cardiac muscle cell development; ISO:MGI.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0007254; P:JNK cascade; ISO:MGI.
DR   GO; GO:0000165; P:MAPK cascade; IPI:MGI.
DR   GO; GO:2000672; P:negative regulation of motor neuron apoptotic process; IMP:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:MGI.
DR   GO; GO:0045740; P:positive regulation of DNA replication; ISO:MGI.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:MGI.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; ISO:MGI.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISO:MGI.
DR   GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISO:MGI.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:MGI.
DR   GO; GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; ISO:MGI.
DR   GO; GO:0009611; P:response to wounding; IMP:MGI.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; ATP-binding; Cytoplasm; Kinase; Methylation;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Stress response; Transferase;
KW   Tyrosine-protein kinase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P45985"
FT   CHAIN           2..397
FT                   /note="Dual specificity mitogen-activated protein kinase
FT                   kinase 4"
FT                   /id="PRO_0000086382"
FT   DOMAIN          100..366
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         106..114
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..38
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          35..50
FT                   /note="D domain"
FT                   /evidence="ECO:0000250"
FT   REGION          362..385
FT                   /note="DVD domain"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        227
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         129
FT                   /note="ATP"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P45985"
FT   MOD_RES         56
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         56
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P45985"
FT   MOD_RES         88
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         255
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         259
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MUTAGEN         129
FT                   /note="K->R: Loss of ATP-binding."
FT                   /evidence="ECO:0000269|PubMed:7997269"
SQ   SEQUENCE   397 AA;  44114 MW;  B99C6688184E5B3D CRC64;
     MAAPSPSGGG GSGGGGGTPG PIGPPASGHP AVSSMQGKRK ALKLNFANPP VKSTARFTLN
     PNTTGVQNPH IERLRTHSIE SSGKLKISPE QHWDFTAEDL KDLGEIGRGA YGSVNKMVHK
     PSGQIMAVKR IRSTVDEKEQ KQLLMDLDVV MRSSDCPYIV QFYGALFREG DCWICMELMS
     TSFDKFYKYV YSVLDDVIPE EILGKITLAT VKALNHLKEN LKIIHRDIKP SNILLDRSGN
     IKLCDFGISG QLVDSIAKTR DAGCRPYMAP ERIDPSASRQ GYDVRSDVWS LGITLYELAT
     GRFPYPKWNS VFDQLTQVVK GDPPQLSNSE EREFSPSFIN FVNLCLTKDE SKRPKYKELL
     KHPFILMYEE RTVEVACYVC KILDQMPATP SSPMYVD
//
ID   MP2K7_HUMAN             Reviewed;         419 AA.
AC   O14733; B2R9S5; D6W659; O14648; O14816; O60452; O60453; Q1PG43; Q8IY10;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   23-FEB-2022, entry version 207.
DE   RecName: Full=Dual specificity mitogen-activated protein kinase kinase 7;
DE            Short=MAP kinase kinase 7;
DE            Short=MAPKK 7;
DE            EC=2.7.12.2;
DE   AltName: Full=JNK-activating kinase 2;
DE   AltName: Full=MAPK/ERK kinase 7;
DE            Short=MEK 7;
DE   AltName: Full=Stress-activated protein kinase kinase 4;
DE            Short=SAPK kinase 4;
DE            Short=SAPKK-4;
DE            Short=SAPKK4;
DE   AltName: Full=c-Jun N-terminal kinase kinase 2;
DE            Short=JNK kinase 2;
DE            Short=JNKK 2;
GN   Name=MAP2K7; Synonyms=JNKK2, MEK7, MKK7, PRKMK7, SKK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart, and Skeletal muscle;
RX   PubMed=9372971; DOI=10.1128/mcb.17.12.7407;
RA   Wu Z., Wu J., Jacinto E., Karin M.;
RT   "Molecular cloning and characterization of human JNKK2, a novel jun NH2-
RT   terminal kinase-specific kinase.";
RL   Mol. Cell. Biol. 17:7407-7416(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=9312068; DOI=10.1074/jbc.272.40.24751;
RA   Lu X., Nemoto S., Lin A.;
RT   "Identification of c-Jun NH2-terminal protein kinase (JNK)-activating
RT   kinase 2 as an activator of JNK but not p38.";
RL   J. Biol. Chem. 272:24751-24754(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND VARIANT PHE-259.
RC   TISSUE=Fetal kidney;
RX   PubMed=9535930; DOI=10.1074/jbc.273.15.9344;
RA   Foltz I.N., Gerl R.E., Wieler J.S., Luckach M., Salmon R.A., Schrader J.W.;
RT   "Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly
RT   conserved c-Jun N-terminal kinase/stress-activated protein kinase
RT   (JNK/SAPK) activated by environmental stresses and physiological stimuli.";
RL   J. Biol. Chem. 273:9344-9351(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), ACTIVITY REGULATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16442502; DOI=10.1016/j.bbrc.2005.12.223;
RA   Michael L., Swantek J., Robinson M.J.;
RT   "Cloning and expression of human mitogen-activated protein kinase kinase
RT   7gamma1.";
RL   Biochem. Biophys. Res. Commun. 341:679-683(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION IN PHOSPHORYLATION OF
RP   MAPK8/JNK1 AND MAPK9/JNK2.
RA   Yang J., New L., Yong J., Han J., Su B.;
RT   "Molecular cloning of human JNKK2 reveals a novel kinase module for c-Jun
RT   N-terminal kinase activation.";
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-260 (ISOFORMS 1/4).
RX   PubMed=9207092; DOI=10.1073/pnas.94.14.7337;
RA   Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., Davis R.J.;
RT   "Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun
RT   NH2-terminal kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7337-7342(1997).
RN   [10]
RP   INTERACTION WITH MAPK8IP1/JIP1 AND MAPK8IP2/JIP2.
RX   PubMed=10490659; DOI=10.1128/mcb.19.10.7245;
RA   Yasuda J., Whitmarsh A.J., Cavanagh J., Sharma M., Davis R.J.;
RT   "The JIP group of mitogen-activated protein kinase scaffold proteins.";
RL   Mol. Cell. Biol. 19:7245-7254(1999).
RN   [11]
RP   CLEAVAGE BY ANTHRAX LETHAL FACTOR.
RX   PubMed=11104681; DOI=10.1042/bj3520739;
RA   Vitale G., Bernardi L., Napolitani G., Mock M., Montecucco C.;
RT   "Susceptibility of mitogen-activated protein kinase kinase family members
RT   to proteolysis by anthrax lethal factor.";
RL   Biochem. J. 352:739-745(2000).
RN   [12]
RP   INTERACTION WITH MAPK8IP3/JIP3.
RX   PubMed=12189133; DOI=10.1074/jbc.m202004200;
RA   Matsuura H., Nishitoh H., Takeda K., Matsuzawa A., Amagasa T., Ito M.,
RA   Yoshioka K., Ichijo H.;
RT   "Phosphorylation-dependent scaffolding role of JSAP1/JIP3 in the ASK1-JNK
RT   signaling pathway. A new mode of regulation of the MAP kinase cascade.";
RL   J. Biol. Chem. 277:40703-40709(2002).
RN   [13]
RP   DOMAIN.
RX   PubMed=15866172; DOI=10.1016/j.molcel.2005.04.001;
RA   Takekawa M., Tatebayashi K., Saito H.;
RT   "Conserved docking site is essential for activation of mammalian MAP kinase
RT   kinases by specific MAP kinase kinase kinases.";
RL   Mol. Cell 18:295-306(2005).
RN   [14]
RP   INTERACTION WITH VRK2.
RX   PubMed=18286207; DOI=10.1371/journal.pone.0001660;
RA   Blanco S., Sanz-Garcia M., Santos C.R., Lazo P.A.;
RT   "Modulation of interleukin-1 transcriptional response by the interaction
RT   between VRK2 and the JIP1 scaffold protein.";
RL   PLoS ONE 3:E1660-E1660(2008).
RN   [15]
RP   REVIEW ON ACTIVITY REGULATION.
RX   PubMed=17496909; DOI=10.1038/sj.onc.1210392;
RA   Raman M., Chen W., Cobb M.H.;
RT   "Differential regulation and properties of MAPKs.";
RL   Oncogene 26:3100-3112(2007).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   REVIEW ON FUNCTION.
RX   PubMed=20801953; DOI=10.1093/jb/mvq098;
RA   Asaoka Y., Nishina H.;
RT   "Diverse physiological functions of MKK4 and MKK7 during early
RT   embryogenesis.";
RL   J. Biochem. 148:393-401(2010).
RN   [18]
RP   INTERACTION WITH RASSF7.
RX   PubMed=21278800; DOI=10.1038/cdd.2010.137;
RA   Takahashi S., Ebihara A., Kajiho H., Kontani K., Nishina H., Katada T.;
RT   "RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the
RT   activity of phosphorylated-MKK7.";
RL   Cell Death Differ. 18:645-655(2011).
RN   [19]
RP   REVIEW ON REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=21333379; DOI=10.1016/j.ejcb.2010.11.008;
RA   Haeusgen W., Herdegen T., Waetzig V.;
RT   "The bottleneck of JNK signaling: molecular and functional characteristics
RT   of MKK4 and MKK7.";
RL   Eur. J. Cell Biol. 90:536-544(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   FUNCTION.
RX   PubMed=28111074; DOI=10.1016/j.cell.2016.12.044;
RA   Huang Y.A., Zhou B., Wernig M., Suedhof T.C.;
RT   "ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and
RT   Abeta Secretion.";
RL   Cell 168:427-441(2017).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 101-405.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Crystal structure of human mitogen-activated protein kinase kinase 7
RT   activated mutant (s287d, t291d).";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [24]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-118; CYS-138; CYS-162; HIS-162 AND
RP   THR-195.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual specificity protein kinase which acts as an essential
CC       component of the MAP kinase signal transduction pathway. Essential
CC       component of the stress-activated protein kinase/c-Jun N-terminal
CC       kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the
CC       only known kinase to directly activate the stress-activated protein
CC       kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3.
CC       MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation,
CC       but they differ in their preference for the phosphorylation site in the
CC       Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of
CC       the Tyr residue and MAP2K7/MKK7 for the Thr residue. The
CC       monophosphorylation of JNKs on the Thr residue is sufficient to
CC       increase JNK activity indicating that MAP2K7/MKK7 is important to
CC       trigger JNK activity, while the additional phosphorylation of the Tyr
CC       residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific
CC       role in JNK signal transduction pathway activated by proinflammatory
CC       cytokines. The MKK/JNK signaling pathway is also involved in
CC       mitochondrial death signaling pathway, including the release cytochrome
CC       c, leading to apoptosis. Part of a non-canonical MAPK signaling
CC       pathway, composed of the upstream MAP3K12 kinase and downstream MAP
CC       kinases MAPK1/ERK2 and MAPK3/ERK1, that enhances the AP-1-mediated
CC       transcription of APP in response to APOE (PubMed:28111074).
CC       {ECO:0000269|PubMed:28111074, ECO:0000269|PubMed:9312068,
CC       ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930,
CC       ECO:0000269|Ref.5}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.2;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.2;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.2;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation by specific MAP
CC       kinase kinase kinases such as MAP3K1/MEKK1, MAP3K3/MEKK3, MAP3K11/MLK3
CC       and MAP3K12/DLK. {ECO:0000269|PubMed:16442502,
CC       ECO:0000269|PubMed:9312068}.
CC   -!- SUBUNIT: Interacts with isoform 1 of VRK2. Interacts (via its D domain)
CC       with its substrates MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3 (By
CC       similarity). Interacts (via its DVD domain) with MAP3Ks activators like
CC       MAP3K5/ASK1 and MAP3K1/MEKK1 (By similarity). Interacts with
CC       MAPK8IP1/JIP1, MAPK8IP2/JIP2 and MAPK8IP3/JIP3 scaffold proteins.
CC       Interacts with RASSF7, the interaction promotes phosphorylation. Found
CC       in a complex with SH3RF1, RAC1, MAP3K11/MLK3, MAPK8IP1/JIP1 and
CC       MAPK8/JNK1. Found in a complex with SH3RF1, RAC2, MAP3K7/TAK1,
CC       MAPK8IP1/JIP1, MAPK8/JNK1 and MAPK9/JNK2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q8CE90, ECO:0000269|PubMed:10490659,
CC       ECO:0000269|PubMed:12189133, ECO:0000269|PubMed:18286207,
CC       ECO:0000269|PubMed:21278800}.
CC   -!- INTERACTION:
CC       O14733; O15519-1: CFLAR; NbExp=2; IntAct=EBI-492605, EBI-4567563;
CC       O14733; O75293: GADD45B; NbExp=8; IntAct=EBI-492605, EBI-448187;
CC       O14733; Q5S007: LRRK2; NbExp=3; IntAct=EBI-492605, EBI-5323863;
CC       O14733; O43318: MAP3K7; NbExp=3; IntAct=EBI-492605, EBI-358684;
CC       O14733; Q9UQF2: MAPK8IP1; NbExp=5; IntAct=EBI-492605, EBI-78404;
CC       O14733-2; P45983: MAPK8; NbExp=3; IntAct=EBI-492627, EBI-286483;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=A;
CC         IsoId=O14733-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=O14733-2; Sequence=VSP_004883;
CC       Name=3; Synonyms=gamma1;
CC         IsoId=O14733-3; Sequence=VSP_022309;
CC       Name=4;
CC         IsoId=O14733-4; Sequence=VSP_022310;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; with highest level of expression in
CC       skeletal muscle. Isoform 3 is found at low levels in placenta, fetal
CC       liver, and skeletal muscle. {ECO:0000269|PubMed:16442502,
CC       ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930}.
CC   -!- DOMAIN: The DVD domain (residues 377-400) contains a conserved docking
CC       site and is found in the mammalian MAP kinase kinases (MAP2Ks). The DVD
CC       sites bind to their specific upstream MAP kinase kinase kinases
CC       (MAP3Ks) and are essential for activation.
CC       {ECO:0000269|PubMed:15866172}.
CC   -!- DOMAIN: The D domain (residues 37-57) contains a conserved docking site
CC       and is required for the binding to MAPK substrates.
CC       {ECO:0000269|PubMed:15866172}.
CC   -!- PTM: Activated by phosphorylation on Ser-271 and Thr-275 by MAP kinase
CC       kinase kinases (MAP3Ks). {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be due to intron retention.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB97813.1; Type=Erroneous termination; Note=Extended C-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAB97813.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF014401; AAB88048.1; -; mRNA.
DR   EMBL; AF006689; AAB97813.1; ALT_SEQ; mRNA.
DR   EMBL; AF013588; AAC16272.1; -; mRNA.
DR   EMBL; AF013589; AAC16273.1; -; mRNA.
DR   EMBL; DQ445915; ABE03013.1; -; mRNA.
DR   EMBL; AF022805; AAC26142.1; -; mRNA.
DR   EMBL; AK313899; BAG36622.1; -; mRNA.
DR   EMBL; CH471139; EAW68964.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68968.1; -; Genomic_DNA.
DR   EMBL; BC038295; AAH38295.1; -; mRNA.
DR   EMBL; AF003199; AAB63374.1; -; mRNA.
DR   CCDS; CCDS42491.1; -. [O14733-1]
DR   CCDS; CCDS74277.1; -. [O14733-3]
DR   CCDS; CCDS74278.1; -. [O14733-4]
DR   RefSeq; NP_001284484.1; NM_001297555.1. [O14733-3]
DR   RefSeq; NP_001284485.1; NM_001297556.1. [O14733-4]
DR   RefSeq; NP_660186.1; NM_145185.3. [O14733-1]
DR   PDB; 2DYL; X-ray; 2.45 A; A=101-405.
DR   PDB; 3WZU; X-ray; 3.01 A; A=103-419.
DR   PDB; 4UX9; X-ray; 2.34 A; F/G/H/I=37-48.
DR   PDB; 5B2K; X-ray; 2.75 A; A=103-419.
DR   PDB; 5B2L; X-ray; 2.10 A; A=103-419.
DR   PDB; 5B2M; X-ray; 3.06 A; A=103-419.
DR   PDB; 5Y8U; X-ray; 2.92 A; A=103-419.
DR   PDB; 5Y90; X-ray; 1.30 A; A=103-419.
DR   PDB; 5Z1D; X-ray; 2.28 A; A=102-419.
DR   PDB; 5Z1E; X-ray; 2.30 A; A=102-419.
DR   PDB; 6IB0; X-ray; 2.60 A; A=101-408.
DR   PDB; 6IB2; X-ray; 2.10 A; A=101-408.
DR   PDB; 6QFL; X-ray; 2.20 A; A=101-408.
DR   PDB; 6QFR; X-ray; 2.30 A; A=101-408.
DR   PDB; 6QFT; X-ray; 2.70 A; A=101-408.
DR   PDB; 6QG4; X-ray; 2.30 A; A=111-408.
DR   PDB; 6QG7; X-ray; 2.10 A; A=101-408.
DR   PDB; 6QHO; X-ray; 2.70 A; A=111-408.
DR   PDB; 6QHR; X-ray; 2.52 A; A=111-408.
DR   PDB; 6YFZ; X-ray; 1.90 A; A=100-405.
DR   PDB; 6YG0; X-ray; 2.00 A; A=100-405.
DR   PDB; 6YG1; X-ray; 2.22 A; A/B/C=60-405.
DR   PDB; 6YG2; X-ray; 2.00 A; A=100-405.
DR   PDB; 6YG3; X-ray; 2.05 A; A=100-405.
DR   PDB; 6YG4; X-ray; 2.30 A; A=100-405.
DR   PDB; 6YG5; X-ray; 2.40 A; A=100-405.
DR   PDB; 6YG6; X-ray; 2.15 A; A/B=100-405.
DR   PDB; 6YG7; X-ray; 2.20 A; A/B=100-405.
DR   PDB; 6YZ4; X-ray; 1.70 A; A=100-405.
DR   PDB; 7CBX; X-ray; 2.06 A; A=103-419.
DR   PDBsum; 2DYL; -.
DR   PDBsum; 3WZU; -.
DR   PDBsum; 4UX9; -.
DR   PDBsum; 5B2K; -.
DR   PDBsum; 5B2L; -.
DR   PDBsum; 5B2M; -.
DR   PDBsum; 5Y8U; -.
DR   PDBsum; 5Y90; -.
DR   PDBsum; 5Z1D; -.
DR   PDBsum; 5Z1E; -.
DR   PDBsum; 6IB0; -.
DR   PDBsum; 6IB2; -.
DR   PDBsum; 6QFL; -.
DR   PDBsum; 6QFR; -.
DR   PDBsum; 6QFT; -.
DR   PDBsum; 6QG4; -.
DR   PDBsum; 6QG7; -.
DR   PDBsum; 6QHO; -.
DR   PDBsum; 6QHR; -.
DR   PDBsum; 6YFZ; -.
DR   PDBsum; 6YG0; -.
DR   PDBsum; 6YG1; -.
DR   PDBsum; 6YG2; -.
DR   PDBsum; 6YG3; -.
DR   PDBsum; 6YG4; -.
DR   PDBsum; 6YG5; -.
DR   PDBsum; 6YG6; -.
DR   PDBsum; 6YG7; -.
DR   PDBsum; 6YZ4; -.
DR   PDBsum; 7CBX; -.
DR   SMR; O14733; -.
DR   BioGRID; 111595; 109.
DR   IntAct; O14733; 39.
DR   MINT; O14733; -.
DR   STRING; 9606.ENSP00000381070; -.
DR   BindingDB; O14733; -.
DR   ChEMBL; CHEMBL3530; -.
DR   DrugCentral; O14733; -.
DR   GuidetoPHARMACOLOGY; 2068; -.
DR   iPTMnet; O14733; -.
DR   MetOSite; O14733; -.
DR   PhosphoSitePlus; O14733; -.
DR   BioMuta; MAP2K7; -.
DR   CPTAC; CPTAC-822; -.
DR   CPTAC; CPTAC-823; -.
DR   EPD; O14733; -.
DR   jPOST; O14733; -.
DR   MassIVE; O14733; -.
DR   MaxQB; O14733; -.
DR   PaxDb; O14733; -.
DR   PeptideAtlas; O14733; -.
DR   PRIDE; O14733; -.
DR   ProteomicsDB; 48192; -. [O14733-1]
DR   ProteomicsDB; 48193; -. [O14733-2]
DR   ProteomicsDB; 48194; -. [O14733-3]
DR   ProteomicsDB; 48195; -. [O14733-4]
DR   Antibodypedia; 1176; 759 antibodies from 42 providers.
DR   DNASU; 5609; -.
DR   Ensembl; ENST00000397979; ENSP00000381066; ENSG00000076984.
DR   Ensembl; ENST00000397981; ENSP00000381068; ENSG00000076984. [O14733-4]
DR   Ensembl; ENST00000397983; ENSP00000381070; ENSG00000076984. [O14733-3]
DR   GeneID; 5609; -.
DR   KEGG; hsa:5609; -.
DR   MANE-Select; ENST00000397979.4; ENSP00000381066.3; NM_145185.4; NP_660186.1.
DR   UCSC; uc002mit.4; human. [O14733-1]
DR   CTD; 5609; -.
DR   DisGeNET; 5609; -.
DR   GeneCards; MAP2K7; -.
DR   HGNC; HGNC:6847; MAP2K7.
DR   HPA; ENSG00000076984; Low tissue specificity.
DR   MIM; 603014; gene.
DR   neXtProt; NX_O14733; -.
DR   OpenTargets; ENSG00000076984; -.
DR   PharmGKB; PA284; -.
DR   VEuPathDB; HostDB:ENSG00000076984; -.
DR   eggNOG; KOG0983; Eukaryota.
DR   GeneTree; ENSGT00940000158914; -.
DR   HOGENOM; CLU_000288_63_23_1; -.
DR   InParanoid; O14733; -.
DR   OMA; CFGYFIT; -.
DR   OrthoDB; 688282at2759; -.
DR   PhylomeDB; O14733; -.
DR   TreeFam; TF350701; -.
DR   BRENDA; 2.7.12.2; 2681.
DR   PathwayCommons; O14733; -.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-HSA-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-HSA-5210891; Uptake and function of anthrax toxins.
DR   SignaLink; O14733; -.
DR   SIGNOR; O14733; -.
DR   BioGRID-ORCS; 5609; 74 hits in 1082 CRISPR screens.
DR   ChiTaRS; MAP2K7; human.
DR   EvolutionaryTrace; O14733; -.
DR   GeneWiki; MAP2K7; -.
DR   GenomeRNAi; 5609; -.
DR   Pharos; O14733; Tchem.
DR   PRO; PR:O14733; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; O14733; protein.
DR   Bgee; ENSG00000076984; Expressed in testis and 239 other tissues.
DR   Genevisible; O14733; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0008545; F:JUN kinase kinase activity; ISS:ARUK-UCL.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IEA:Ensembl.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0019903; F:protein phosphatase binding; ISS:BHF-UCL.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0072709; P:cellular response to sorbitol; IEA:Ensembl.
DR   GO; GO:0090398; P:cellular senescence; TAS:Reactome.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007254; P:JNK cascade; ISS:BHF-UCL.
DR   GO; GO:0000165; P:MAPK cascade; IBA:GO_Central.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; ISS:BHF-UCL.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IMP:BHF-UCL.
DR   GO; GO:1904355; P:positive regulation of telomere capping; IMP:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IMP:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0009408; P:response to heat; IDA:UniProtKB.
DR   GO; GO:0006970; P:response to osmotic stress; IDA:UniProtKB.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IDA:UniProtKB.
DR   GO; GO:0009411; P:response to UV; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; IDA:UniProtKB.
DR   DisProt; DP00841; -.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; ATP-binding;
KW   Coiled coil; Cytoplasm; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Stress response; Transferase;
KW   Tyrosine-protein kinase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..419
FT                   /note="Dual specificity mitogen-activated protein kinase
FT                   kinase 7"
FT                   /id="PRO_0000086388"
FT   DOMAIN          120..380
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         126..134
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          18..76
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          37..57
FT                   /note="D domain"
FT                   /evidence="ECO:0000250"
FT   REGION          377..400
FT                   /note="DVD domain"
FT   COILED          2..30
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        18..33
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        243
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         149
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            44..45
FT                   /note="Cleavage; by anthrax lethal factor"
FT   SITE            76..77
FT                   /note="Cleavage; by anthrax lethal factor"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         271
FT                   /note="Phosphoserine; by MAP3K"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         275
FT                   /note="Phosphothreonine; by MAP3K"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         411
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         42
FT                   /note="T -> IIVITLSPAPAPSQRAA (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16442502"
FT                   /id="VSP_022309"
FT   VAR_SEQ         111
FT                   /note="Q -> QVPPSLWRGEGGGPARLDPSWERQWGAGGGGRAPGTLQPSLSSQ
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9535930"
FT                   /id="VSP_004883"
FT   VAR_SEQ         312
FT                   /note="L -> LPCPSPSQ (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022310"
FT   VARIANT         118
FT                   /note="N -> S (in dbSNP:rs56316660)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040825"
FT   VARIANT         138
FT                   /note="R -> C (in dbSNP:rs56106612)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040826"
FT   VARIANT         162
FT                   /note="R -> C (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040827"
FT   VARIANT         162
FT                   /note="R -> H (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040828"
FT   VARIANT         195
FT                   /note="A -> T (in dbSNP:rs55800262)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040829"
FT   VARIANT         259
FT                   /note="L -> F (in dbSNP:rs1053566)"
FT                   /evidence="ECO:0000269|PubMed:9535930"
FT                   /id="VAR_029890"
FT   CONFLICT        94
FT                   /note="Q -> H (in Ref. 2; AAB97813)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        106
FT                   /note="L -> P (in Ref. 4; ABE03013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        133
FT                   /note="Q -> P (in Ref. 2; AAB97813)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        142
FT                   /note="T -> N (in Ref. 1; AAB88048)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        407
FT                   /note="S -> N (in Ref. 2; AAB97813)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        415
FT                   /note="L -> LG (in Ref. 2; AAB97813)"
FT                   /evidence="ECO:0000305"
FT   STRAND          104..108
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          111..115
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           117..119
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          120..126
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          129..138
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   TURN            140..142
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          145..152
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           157..171
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   TURN            173..175
FT                   /evidence="ECO:0007829|PDB:5B2L"
FT   STRAND          182..187
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          189..196
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           203..210
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           216..237
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           246..248
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          249..251
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          257..259
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   TURN            262..265
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           281..283
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           286..289
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          292..297
FT                   /evidence="ECO:0007829|PDB:5B2L"
FT   HELIX           302..317
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   TURN            321..324
FT                   /evidence="ECO:0007829|PDB:6IB2"
FT   HELIX           328..337
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   STRAND          345..347
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           351..360
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           365..367
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           371..374
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           378..385
FT                   /evidence="ECO:0007829|PDB:5Y90"
FT   HELIX           390..401
FT                   /evidence="ECO:0007829|PDB:5Y90"
SQ   SEQUENCE   419 AA;  47485 MW;  F1B22E050F54299A CRC64;
     MAASSLEQKL SRLEAKLKQE NREARRRIDL NLDISPQRPR PTLQLPLAND GGSRSPSSES
     SPQHPTPPAR PRHMLGLPST LFTPRSMESI EIDQKLQEIM KQTGYLTIGG QRYQAEINDL
     ENLGEMGSGT CGQVWKMRFR KTGHVIAVKQ MRRSGNKEEN KRILMDLDVV LKSHDCPYIV
     QCFGTFITNT DVFIAMELMG TCAEKLKKRM QGPIPERILG KMTVAIVKAL YYLKEKHGVI
     HRDVKPSNIL LDERGQIKLC DFGISGRLVD SKAKTRSAGC AAYMAPERID PPDPTKPDYD
     IRADVWSLGI SLVELATGQF PYKNCKTDFE VLTKVLQEEP PLLPGHMGFS GDFQSFVKDC
     LTKDHRKRPK YNKLLEHSFI KRYETLEVDV ASWFKDVMAK TESPRTSGVL SQPHLPFFR
//
ID   Q967X2_CIOIN            Unreviewed;       215 AA.
AC   Q967X2; A0A1W3JIL0;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   19-JAN-2022, entry version 106.
DE   RecName: Full=Casein kinase II subunit beta {ECO:0000256|ARBA:ARBA00017775, ECO:0000256|RuleBase:RU361268};
DE            Short=CK II beta {ECO:0000256|RuleBase:RU361268};
GN   Name=CK2B {ECO:0000313|EMBL:AAK50003.1};
GN   Synonyms=Ci-casein kinase II b {ECO:0000313|EMBL:BAE06342.1},
GN   ck2b {ECO:0000313|Ensembl:ENSCINP00000008085};
OS   Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis).
OC   Eukaryota; Metazoa; Chordata; Tunicata; Ascidiacea; Phlebobranchia;
OC   Cionidae; Ciona.
OX   NCBI_TaxID=7719 {ECO:0000313|EMBL:AAK50003.1};
RN   [1] {ECO:0000313|Proteomes:UP000008144}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12481130; DOI=10.1126/science.1080049;
RA   Dehal P., Satou Y., Campbell R.K., Chapman J., Degnan B., De Tomaso A.,
RA   Davidson B., Di Gregorio A., Gelpke M., Goodstein D.M., Harafuji N.,
RA   Hastings K.E., Ho I., Hotta K., Huang W., Kawashima T., Lemaire P.,
RA   Martinez D., Meinertzhagen I.A., Necula S., Nonaka M., Putnam N., Rash S.,
RA   Saiga H., Satake M., Terry A., Yamada L., Wang H.G., Awazu S., Azumi K.,
RA   Boore J., Branno M., Chin-Bow S., DeSantis R., Doyle S., Francino P.,
RA   Keys D.N., Haga S., Hayashi H., Hino K., Imai K.S., Inaba K., Kano S.,
RA   Kobayashi K., Kobayashi M., Lee B.I., Makabe K.W., Manohar C., Matassi G.,
RA   Medina M., Mochizuki Y., Mount S., Morishita T., Miura S., Nakayama A.,
RA   Nishizaka S., Nomoto H., Ohta F., Oishi K., Rigoutsos I., Sano M.,
RA   Sasaki A., Sasakura Y., Shoguchi E., Shin-i T., Spagnuolo A., Stainier D.,
RA   Suzuki M.M., Tassy O., Takatori N., Tokuoka M., Yagi K., Yoshizaki F.,
RA   Wada S., Zhang C., Hyatt P.D., Larimer F., Detter C., Doggett N.,
RA   Glavina T., Hawkins T., Richardson P., Lucas S., Kohara Y., Levine M.,
RA   Satoh N., Rokhsar D.S.;
RT   "The draft genome of Ciona intestinalis: insights into chordate and
RT   vertebrate origins.";
RL   Science 298:2157-2167(2002).
RN   [2] {ECO:0000313|EMBL:BAE06342.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12736827; DOI=10.1007/s00427-003-0330-z;
RA   Satou Y., Satoh N.;
RT   "Genomewide surveys of developmentally relevant genes in Ciona
RT   intestinalis.";
RL   Dev. Genes Evol. 213:211-212(2003).
RN   [3] {ECO:0000313|EMBL:BAE06342.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=15269171; DOI=10.1242/dev.01270;
RA   Imai K.S., Hino K., Yagi K., Satoh N., Satou Y.;
RT   "Gene expression profiles of transcription factors and signaling molecules
RT   in the ascidian embryo: towards a comprehensive understanding of gene
RT   networks.";
RL   Development 131:4047-4058(2004).
RN   [4] {ECO:0000313|EMBL:AAK50003.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=15159401; DOI=10.1074/jbc.M401085200;
RA   Russo G.L., Tosto M., Mupo A., Castellano I., Cuomo A., Tosti E.;
RT   "Biochemical and functional characterization of protein kinase CK2 in
RT   ascidian Ciona intestinalis oocytes at fertilization. Cloning and sequence
RT   analysis of cDNA for alpha and beta subunits.";
RL   J. Biol. Chem. 279:33012-33023(2004).
RN   [5] {ECO:0000313|EMBL:BAE06342.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Satou Y.;
RT   "Expressed genes in Ciona intestinalis.";
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|Ensembl:ENSCINP00000008085}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -!- FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the
CC       kinase complex regulates the basal catalytic activity of the alpha
CC       subunit a constitutively active serine/threonine-protein kinase that
CC       phosphorylates a large number of substrates containing acidic residues
CC       C-terminal to the phosphorylated serine or threonine. Participates in
CC       Wnt signaling. {ECO:0000256|RuleBase:RU361268}.
CC   -!- SUBUNIT: Tetramer of two alpha and two beta subunits.
CC       {ECO:0000256|RuleBase:RU361268}.
CC   -!- SIMILARITY: Belongs to the casein kinase 2 subunit beta family.
CC       {ECO:0000256|ARBA:ARBA00006941, ECO:0000256|RuleBase:RU361268}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EAAA01000113; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF360544; AAK50003.1; -; mRNA.
DR   EMBL; AB210337; BAE06342.1; -; mRNA.
DR   RefSeq; NP_001027591.1; NM_001032419.1.
DR   RefSeq; XP_009862100.1; XM_009863798.2.
DR   STRING; 7719.XP_009862100.1; -.
DR   Ensembl; ENSCINT00000008085; ENSCINP00000008085; ENSCING00000003902.
DR   GeneID; 445589; -.
DR   KEGG; cin:445589; -.
DR   CTD; 692538; -.
DR   GeneTree; ENSGT00390000003781; -.
DR   HOGENOM; CLU_034027_3_3_1; -.
DR   OMA; LCQSQPL; -.
DR   OrthoDB; 1335521at2759; -.
DR   TreeFam; TF314462; -.
DR   Proteomes; UP000008144; Unassembled WGS sequence.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005956; C:protein kinase CK2 complex; IBA:GO_Central.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0019887; F:protein kinase regulator activity; IBA:GO_Central.
DR   GO; GO:0080163; P:regulation of protein serine/threonine phosphatase activity; IBA:GO_Central.
DR   Gene3D; 1.10.1820.10; -; 1.
DR   InterPro; IPR016149; Casein_kin_II_reg-sub_N.
DR   InterPro; IPR035991; Casein_kinase_II_beta-like.
DR   InterPro; IPR000704; Casein_kinase_II_reg-sub.
DR   PANTHER; PTHR11740; PTHR11740; 1.
DR   Pfam; PF01214; CK_II_beta; 1.
DR   PRINTS; PR00472; CASNKINASEII.
DR   SMART; SM01085; CK_II_beta; 1.
DR   SUPFAM; SSF57798; SSF57798; 1.
PE   2: Evidence at transcript level;
KW   Kinase {ECO:0000313|EMBL:AAK50003.1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000008144};
KW   Transferase {ECO:0000313|EMBL:AAK50003.1}.
SQ   SEQUENCE   215 AA;  24938 MW;  62A43DCB6C6CEF3F CRC64;
     MSSSEEVSWI SWFCGLRGNE FFCEVDEDYI QDKFNLTGLG EQVPHYRQAL DMILDLEPDD
     DLEDNTNQSD LIEQAAEMLY GLIHARYTLT NRGIAQMLEK YQQGDFGHCS RVYCENQPML
     PIGLSDVPGE AMVKLYCPKC QDVYTPKSSR HHHTDGAYFG TGFPHMLFMV HPEYRPKRPT
     NQFVSRLFGF KIHPMAYQLQ YQASQKLKNP SKLRH
//
ID   A7RQU9_NEMVE            Unreviewed;       376 AA.
AC   A7RQU9;
DT   02-OCT-2007, integrated into UniProtKB/TrEMBL.
DT   02-OCT-2007, sequence version 1.
DT   19-JAN-2022, entry version 86.
DE   SubName: Full=Cytoplasmic creatine kinase protein {ECO:0000313|EMBL:BAL73226.1};
DE   SubName: Full=Predicted protein {ECO:0000313|EMBL:EDO46231.1};
GN   Name=cytoplasmic creatine kinase {ECO:0000313|EMBL:BAL73226.1};
GN   ORFNames=v1g234345 {ECO:0000313|EMBL:EDO46231.1};
OS   Nematostella vectensis (Starlet sea anemone).
OC   Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
OC   Edwardsiidae; Nematostella.
OX   NCBI_TaxID=45351 {ECO:0000313|Proteomes:UP000001593};
RN   [1] {ECO:0000313|EMBL:EDO46231.1, ECO:0000313|Proteomes:UP000001593}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=CH2 X CH6 {ECO:0000313|Proteomes:UP000001593};
RX   PubMed=17615350; DOI=10.1126/science.1139158;
RA   Putnam N.H., Srivastava M., Hellsten U., Dirks B., Chapman J., Salamov A.,
RA   Terry A., Shapiro H., Lindquist E., Kapitonov V.V., Jurka J.,
RA   Genikhovich G., Grigoriev I.V., Lucas S.M., Steele R.E., Finnerty J.R.,
RA   Technau U., Martindale M.Q., Rokhsar D.S.;
RT   "Sea anemone genome reveals ancestral eumetazoan gene repertoire and
RT   genomic organization.";
RL   Science 317:86-94(2007).
RN   [2] {ECO:0000313|EMBL:BAL73226.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22305986; DOI=10.1016/j.gene.2012.01.036;
RA   Uda K., Ellington W.R., Suzuki T.;
RT   "A diverse array of creatine kinase and arginine kinase isoform genes is
RT   present in the starlet sea anemone Nematostella vectensis, a cnidarian
RT   model system for studying developmental evolution.";
RL   Gene 497:214-227(2012).
CC   -!- SIMILARITY: Belongs to the ATP:guanido phosphotransferase family.
CC       {ECO:0000256|ARBA:ARBA00006798, ECO:0000256|PROSITE-ProRule:PRU00842,
CC       ECO:0000256|RuleBase:RU000505}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB665525; BAL73226.1; -; mRNA.
DR   EMBL; DS469529; EDO46231.1; -; Genomic_DNA.
DR   RefSeq; XP_001638294.1; XM_001638244.1.
DR   STRING; 45351.EDO46231; -.
DR   EnsemblMetazoa; EDO46231; EDO46231; NEMVEDRAFT_v1g234345.
DR   GeneID; 5518278; -.
DR   KEGG; nve:5518278; -.
DR   eggNOG; KOG3581; Eukaryota.
DR   HOGENOM; CLU_019868_4_2_1; -.
DR   OMA; RAVENMS; -.
DR   OrthoDB; 825025at2759; -.
DR   Proteomes; UP000001593; Unassembled WGS sequence.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004111; F:creatine kinase activity; IBA:GO_Central.
DR   GO; GO:0016301; F:kinase activity; IBA:GO_Central.
DR   GO; GO:0046314; P:phosphocreatine biosynthetic process; IBA:GO_Central.
DR   Gene3D; 1.10.135.10; -; 1.
DR   InterPro; IPR000749; ATP-guanido_PTrfase.
DR   InterPro; IPR022415; ATP-guanido_PTrfase_AS.
DR   InterPro; IPR022414; ATP-guanido_PTrfase_cat.
DR   InterPro; IPR022413; ATP-guanido_PTrfase_N.
DR   InterPro; IPR036802; ATP-guanido_PTrfase_N_sf.
DR   InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom.
DR   PANTHER; PTHR11547; PTHR11547; 2.
DR   Pfam; PF00217; ATP-gua_Ptrans; 1.
DR   Pfam; PF02807; ATP-gua_PtransN; 1.
DR   SUPFAM; SSF48034; SSF48034; 1.
DR   SUPFAM; SSF55931; SSF55931; 1.
DR   PROSITE; PS00112; PHOSPHAGEN_KINASE; 1.
DR   PROSITE; PS51510; PHOSPHAGEN_KINASE_C; 1.
DR   PROSITE; PS51509; PHOSPHAGEN_KINASE_N; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|ARBA:ARBA00022840, ECO:0000256|PROSITE-
KW   ProRule:PRU00843};
KW   Kinase {ECO:0000256|ARBA:ARBA00022777, ECO:0000256|PROSITE-
KW   ProRule:PRU00843};
KW   Nucleotide-binding {ECO:0000256|ARBA:ARBA00022840, ECO:0000256|PROSITE-
KW   ProRule:PRU00843}; Reference proteome {ECO:0000313|Proteomes:UP000001593};
KW   Transferase {ECO:0000256|ARBA:ARBA00022777, ECO:0000256|PROSITE-
KW   ProRule:PRU00843}.
FT   DOMAIN          9..95
FT                   /note="Phosphagen kinase N-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51509"
FT   DOMAIN          121..364
FT                   /note="Phosphagen kinase C-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51510"
FT   NP_BIND         124..128
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00843"
FT   NP_BIND         288..292
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00843"
FT   NP_BIND         317..322
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00843"
FT   BINDING         187
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00843"
FT   BINDING         232
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00843"
SQ   SEQUENCE   376 AA;  42117 MW;  D5933E6281037882 CRC64;
     MTSVKSAYKQ FSADDDFPDL SQHNNYMAKV LTKEIYRSLR DKSTKNGFTL DDIIQTGVDN
     PGHPFIMTVG CVAGDEESYD VFAELLDPVI ELRHGGYKKT DKHKTDLNPD NLKGGALDPK
     YVLSSRVRTG RSIRGFCLPP HCSRAERRSV EKISVDALAK LDGEFKGKYY PLNKMTDEEQ
     EQLINDHFLF DKPVSPLLTC AGMARDWPDA RGIWHNENKN FLVWVNEEDH TRVISMEKGG
     DMRAVFTRFC NGLNKVESLI KEAGYEFMWN EHLGYVLTCP SNLGTGLRAG VHLKIPLLSQ
     DEKRLDAILA KLKLQKRGTG GVDTASVGGV YDISNADRIG FSEVELVQGM VDGVGLLIEM
     EKRLEEGKAI DDLIPK
//
ID   Q9NA00_9CRUS            Unreviewed;       494 AA.
AC   Q9NA00;
DT   01-OCT-2000, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2000, sequence version 1.
DT   19-JAN-2022, entry version 89.
DE   RecName: Full=Non-specific protein-tyrosine kinase {ECO:0000256|ARBA:ARBA00011903};
DE            EC=2.7.10.2 {ECO:0000256|ARBA:ARBA00011903};
DE   Flags: Fragment;
GN   Name=wee1-like CDK tyrosine kinase {ECO:0000313|EMBL:CAB99477.1};
OS   Daphnia magna.
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Branchiopoda;
OC   Diplostraca; Cladocera; Anomopoda; Daphniidae; Daphnia.
OX   NCBI_TaxID=35525 {ECO:0000313|EMBL:CAB99477.1};
RN   [1] {ECO:0000313|EMBL:CAB99477.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Richards J.R., Cryer J., Kille P.;
RT   "Isolation of genes from Daphnia magna.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000256|PIRSR:PIRSR037281-3};
CC       Note=Binds 2 magnesium ions per subunit.
CC       {ECO:0000256|PIRSR:PIRSR037281-3};
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC       {ECO:0000256|RuleBase:RU000304}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ292557; CAB99477.1; -; mRNA.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR017164; Wee1-like_protein_kinase.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037281; Wee1-like_protein_kinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|ARBA:ARBA00022840, ECO:0000256|PIRSR:PIRSR037281-
KW   2}; Kinase {ECO:0000256|RuleBase:RU000304};
KW   Magnesium {ECO:0000256|PIRSR:PIRSR037281-3};
KW   Metal-binding {ECO:0000256|PIRSR:PIRSR037281-3};
KW   Nucleotide-binding {ECO:0000256|ARBA:ARBA00022840,
KW   ECO:0000256|PIRSR:PIRSR037281-2};
KW   Serine/threonine-protein kinase {ECO:0000256|RuleBase:RU000304};
KW   Transferase {ECO:0000256|RuleBase:RU000304}.
FT   DOMAIN          212..486
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000259|PROSITE:PS50011"
FT   NP_BIND         218..226
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR037281-2"
FT   REGION          23..82
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          129..154
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        33..50
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        339
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR037281-1"
FT   METAL           344
FT                   /note="Magnesium; via carbonyl oxygen"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR037281-3"
FT   METAL           381
FT                   /note="Magnesium; via carbonyl oxygen"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR037281-3"
FT   BINDING         241
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR037281-2"
FT   BINDING         242
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU10141"
FT   NON_TER         494
FT                   /evidence="ECO:0000313|EMBL:CAB99477.1"
SQ   SEQUENCE   494 AA;  55301 MW;  BC10BC034E593178 CRC64;
     MDRDIEMEEN HCRIAQRLEF PLSDEEDLHE ASTGNNRTSS NSSSDRLDSS GSDEGLGMTI
     RITSPRKPRF IRSRAREPMS PPYSGVRALR LFDSPATPKT LLENSSAIMT PVLATPAPRN
     RMRTLFTMSS TKSSDKKDNM NTPPAANVNP FTPTGMLLTS KKRTRSKRSL NGSLVNSFDE
     EVHEATDESD EEMPPKRIAL HQTSVPRYHK EFHEICLIGK GEFGSVHKCL NRLDGCTYAV
     KKSLMPVAGS PNERSALNEV WAHAVLGQHP HAVRYYSAWA ENGHMIIQNE FCNSGTLEEL
     IRTNQLNNVT VNEPQLKSTL LQIAEGLHYI HSKQLAHMDI KPGNIFICRE NSDDCSVHHD
     SDDGFDELDD DYGSVTYKIG DLGHVTSVVQ PIVEEGDCRY LPVEILRENY EHLTKADIFS
     LGLTIYEMAG GGQLPKNGDE WHAIRQGRLP YNGRYSIELH NLLELMIHPD PTLRPSTQVL
     TQHPVLGPNG AKSK
//
ID   Q91356_COTCO            Unreviewed;       367 AA.
AC   Q91356;
DT   01-NOV-1996, integrated into UniProtKB/TrEMBL.
DT   01-NOV-1996, sequence version 1.
DT   02-JUN-2021, entry version 95.
DE   RecName: Full=Vascular endothelial growth factor receptor 3 {ECO:0000256|ARBA:ARBA00022258};
DE   Flags: Fragment;
GN   Name=endothelial kinase Quek2 {ECO:0000313|EMBL:AAB28128.1};
OS   Coturnix coturnix (Common quail) (Tetrao coturnix).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC   Perdicinae; Coturnix.
OX   NCBI_TaxID=9091 {ECO:0000313|EMBL:AAB28128.1};
RN   [1] {ECO:0000313|EMBL:AAB28128.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=8396413; DOI=10.1016/0925-4773(93)90096-G;
RA   Eichmann A., Marcelle C., Breant C., Le Douarin N.M.;
RT   "Two molecules related to the VEGF receptor are expressed in early
RT   endothelial cells during avian embryonic development.";
RL   Mech. Dev. 42:33-48(1993).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S65207; AAB28128.1; -; mRNA.
DR   PIR; B56598; B56598.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005021; F:vascular endothelial growth factor-activated receptor activity; IEA:InterPro.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR009137; VEGFR3_rcpt.
DR   PANTHER; PTHR24416:SF562; PTHR24416:SF562; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   2: Evidence at transcript level;
KW   Kinase {ECO:0000313|EMBL:AAB28128.1};
KW   Transferase {ECO:0000313|EMBL:AAB28128.1}.
FT   DOMAIN          1..173
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000259|PROSITE:PS50011"
FT   REGION          184..212
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          287..367
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        184..209
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        321..335
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         367
FT                   /evidence="ECO:0000313|EMBL:AAB28128.1"
SQ   SEQUENCE   367 AA;  41793 MW;  04442B35940027A0 CRC64;
     WMDLWQSPLT MEDLICYSFQ VARGMEFLAS RKCIHRDLAA RNILLSENNV VKICDFGLAR
     DIYKDPDYVR KGSARLPLKW MAPESIFDKV YTTQSDVWSL GVLLWEIFSL GASPYPGVQI
     NEEFCQRFKD GTRMRAPEYT TAEIYRIMLS CWHGDPKERP TFSDLVEILG NLLQENVQQE
     GKDYIPLNDS HSSEDDGFSQ VPSSAQQNSD EEDFDMRIRC HSLAARYYNC VSFPGCLTGG
     NQIRCSSRIK TFEEFPMTHT MYKAHPDNQT DSGMVLASEE FERIENRHRK EGGFSSKGPN
     RTAELSAEQS DLRGRCRPSY GSQVGGQTFY NSEYGELSEH SEDRSCTPPA EGASPPALHA
     SFFSEQY
//
ID   Q9PU23_TRASE            Unreviewed;       216 AA.
AC   Q9PU23;
DT   01-MAY-2000, integrated into UniProtKB/TrEMBL.
DT   01-MAY-2000, sequence version 1.
DT   29-SEP-2021, entry version 82.
DE   RecName: Full=Pyruvate kinase {ECO:0000256|ARBA:ARBA00012142, ECO:0000256|RuleBase:RU000504};
DE            EC=2.7.1.40 {ECO:0000256|ARBA:ARBA00012142, ECO:0000256|RuleBase:RU000504};
DE   Flags: Fragment;
GN   Name=pyruvate kinase {ECO:0000313|EMBL:CAB61266.1};
OS   Trachemys scripta elegans (Red-eared slider turtle).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira;
OC   Testudinoidea; Emydidae; Trachemys.
OX   NCBI_TaxID=31138 {ECO:0000313|EMBL:CAB61266.1};
RN   [1] {ECO:0000313|EMBL:CAB61266.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:CAB61266.1};
RX   PubMed=10555283;
RA   Hughes S., Zelus D., Mouchiroud D.;
RT   "Warm-blooded isochore structure in Nile crocodile and turtle.";
RL   Mol. Biol. Evol. 16:1521-1527(1999).
RN   [2] {ECO:0000313|EMBL:CAB61266.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:CAB61266.1};
RA   Hughes S.N.;
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + pyruvate = ADP + H(+) + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:18157, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:58702, ChEBI:CHEBI:456216;
CC         EC=2.7.1.40; Evidence={ECO:0000256|ARBA:ARBA00001174,
CC         ECO:0000256|RuleBase:RU000504};
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000256|ARBA:ARBA00001958};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000256|ARBA:ARBA00001946};
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 5/5. {ECO:0000256|ARBA:ARBA00004997,
CC       ECO:0000256|RuleBase:RU000504}.
CC   -!- SIMILARITY: Belongs to the pyruvate kinase family.
CC       {ECO:0000256|ARBA:ARBA00008663, ECO:0000256|RuleBase:RU000504}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ243136; CAB61266.1; -; mRNA.
DR   UniPathway; UPA00109; UER00188.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030955; F:potassium ion binding; IEA:InterPro.
DR   GO; GO:0004743; F:pyruvate kinase activity; IEA:UniProtKB-EC.
DR   Gene3D; 3.20.20.60; -; 1.
DR   InterPro; IPR001697; Pyr_Knase.
DR   InterPro; IPR015813; Pyrv/PenolPyrv_Kinase-like_dom.
DR   InterPro; IPR040442; Pyrv_Kinase-like_dom_sf.
DR   InterPro; IPR011037; Pyrv_Knase-like_insert_dom_sf.
DR   InterPro; IPR015793; Pyrv_Knase_brl.
DR   PANTHER; PTHR11817; PTHR11817; 1.
DR   Pfam; PF00224; PK; 1.
DR   PRINTS; PR01050; PYRUVTKNASE.
DR   SUPFAM; SSF50800; SSF50800; 1.
DR   SUPFAM; SSF51621; SSF51621; 1.
DR   TIGRFAMs; TIGR01064; pyruv_kin; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|ARBA:ARBA00022840};
KW   Glycolysis {ECO:0000256|ARBA:ARBA00023152, ECO:0000256|RuleBase:RU000504};
KW   Kinase {ECO:0000256|ARBA:ARBA00022777, ECO:0000256|RuleBase:RU000504};
KW   Magnesium {ECO:0000256|ARBA:ARBA00022842, ECO:0000256|RuleBase:RU000504};
KW   Metal-binding {ECO:0000256|ARBA:ARBA00022723};
KW   Nucleotide-binding {ECO:0000256|ARBA:ARBA00022840};
KW   Pyruvate {ECO:0000256|ARBA:ARBA00023317, ECO:0000313|EMBL:CAB61266.1};
KW   Transferase {ECO:0000256|ARBA:ARBA00022777, ECO:0000256|RuleBase:RU000504}.
FT   DOMAIN          4..216
FT                   /note="PK"
FT                   /evidence="ECO:0000259|Pfam:PF00224"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:CAB61266.1"
FT   NON_TER         216
FT                   /evidence="ECO:0000313|EMBL:CAB61266.1"
SQ   SEQUENCE   216 AA;  23513 MW;  7E8F42877545B562 CRC64;
     KGSGTAEVEL KKGATLKVTL DNAFMEKCDE NVLWLDYKNL PNVVDVGSKI YIDDGLISLQ
     VKGKGADYVL TEVENGGMLG SKKGVNLPGA AVDLPAVSEK DIQDLKFGVE QDVDMVFASF
     IRKAADVHAV RQVLGEKGKX IKIISEIENH EGVRRFDEVL EASDGIMVAR GDLGIEIPAE
     KVFLAQKMMI GRCNRAGKPI ICATQMLESM IKKPRP
//
ID   Q90WS6_9SAUR            Unreviewed;       215 AA.
AC   Q90WS6;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   29-SEP-2021, entry version 81.
DE   RecName: Full=Pyruvate kinase {ECO:0000256|ARBA:ARBA00012142, ECO:0000256|RuleBase:RU000504};
DE            EC=2.7.1.40 {ECO:0000256|ARBA:ARBA00012142, ECO:0000256|RuleBase:RU000504};
DE   Flags: Fragment;
GN   Name=pyruvate kinase {ECO:0000313|EMBL:CAC69539.1};
OS   Elaphe sp.
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Colubridae; Colubrinae; Elaphe;
OC   unclassified Elaphe.
OX   NCBI_TaxID=114965 {ECO:0000313|EMBL:CAC69539.1};
RN   [1] {ECO:0000313|EMBL:CAC69539.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:CAC69539.1};
RA   Hughes S.N.;
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:CAC69539.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:CAC69539.1};
RA   Hughes S., Laurin M., Gouy M., Mouchiroud D.;
RT   "The phylogenetic position of turtles among sauropsidae remains contentious
RT   with new nuclear data.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + pyruvate = ADP + H(+) + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:18157, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:58702, ChEBI:CHEBI:456216;
CC         EC=2.7.1.40; Evidence={ECO:0000256|ARBA:ARBA00001174,
CC         ECO:0000256|RuleBase:RU000504};
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000256|ARBA:ARBA00001958};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000256|ARBA:ARBA00001946};
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 5/5. {ECO:0000256|ARBA:ARBA00004997,
CC       ECO:0000256|RuleBase:RU000504}.
CC   -!- SIMILARITY: Belongs to the pyruvate kinase family.
CC       {ECO:0000256|ARBA:ARBA00008663, ECO:0000256|RuleBase:RU000504}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ286864; CAC69539.1; -; mRNA.
DR   UniPathway; UPA00109; UER00188.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030955; F:potassium ion binding; IEA:InterPro.
DR   GO; GO:0004743; F:pyruvate kinase activity; IEA:UniProtKB-EC.
DR   Gene3D; 3.20.20.60; -; 1.
DR   InterPro; IPR001697; Pyr_Knase.
DR   InterPro; IPR015813; Pyrv/PenolPyrv_Kinase-like_dom.
DR   InterPro; IPR040442; Pyrv_Kinase-like_dom_sf.
DR   InterPro; IPR011037; Pyrv_Knase-like_insert_dom_sf.
DR   InterPro; IPR018209; Pyrv_Knase_AS.
DR   InterPro; IPR015793; Pyrv_Knase_brl.
DR   PANTHER; PTHR11817; PTHR11817; 1.
DR   Pfam; PF00224; PK; 1.
DR   PRINTS; PR01050; PYRUVTKNASE.
DR   SUPFAM; SSF50800; SSF50800; 1.
DR   SUPFAM; SSF51621; SSF51621; 1.
DR   PROSITE; PS00110; PYRUVATE_KINASE; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|ARBA:ARBA00022840};
KW   Glycolysis {ECO:0000256|ARBA:ARBA00023152, ECO:0000256|RuleBase:RU000504};
KW   Kinase {ECO:0000256|ARBA:ARBA00022777, ECO:0000256|RuleBase:RU000504};
KW   Magnesium {ECO:0000256|ARBA:ARBA00022842, ECO:0000256|RuleBase:RU000504};
KW   Metal-binding {ECO:0000256|ARBA:ARBA00022723};
KW   Nucleotide-binding {ECO:0000256|ARBA:ARBA00022840};
KW   Pyruvate {ECO:0000256|ARBA:ARBA00023317, ECO:0000313|EMBL:CAC69539.1};
KW   Transferase {ECO:0000256|ARBA:ARBA00022777, ECO:0000256|RuleBase:RU000504}.
FT   DOMAIN          4..214
FT                   /note="PK"
FT                   /evidence="ECO:0000259|Pfam:PF00224"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:CAC69539.1"
FT   NON_TER         215
FT                   /evidence="ECO:0000313|EMBL:CAC69539.1"
SQ   SEQUENCE   215 AA;  23520 MW;  50FED93ADFDA0C15 CRC64;
     KGSGTAEVEL KKGATLKVTL DNAYMEKCDE HVLWVDYKNI IKVVEIGSKI YVDDGLISLK
     VKEKGADFIM TEIENGGLLG SKKGVNLPGA AVDLPAVPEK DIQDLKFGVE QDVDMVLASF
     IRKAADVHAV RKVLGEKGKN IKIISKIENH EGVRRFDEIM EASDGIMVAR GDLGIEIPAE
     KVFLAQKMMI GRCNRAGKPI ICATQMLESM IKKPP
//
